Vanguard Pharma continues to expand its product portfolio to new and exciting parts of the healthcare business.

 

Kevin Danylchuk, Vanguard’s president and general manager, commented, "As of the summer of 2019, we are supporting clients with selling efforts in all of the following areas: prescription pharmaceuticals including both hospital specialty products and office-based products, OTC products, consumer products, medical devices, capital equipment, retail representation, and physician revenue programs. Our business has evolved significantly to become very diverse. As I like to say: 'If it’s in healthcare, we can help you sell it!'